1. Home
  2. ACXP vs AIHS Comparison

ACXP vs AIHS Comparison

Compare ACXP & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.50

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.42

Market Cap

5.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACXP
AIHS
Founded
2017
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
5.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
ACXP
AIHS
Price
$1.50
$1.42
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$95.50
N/A
AVG Volume (30 Days)
78.2K
27.8K
Earning Date
05-12-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,546,127.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$0.25
52 Week High
$8.34
$8.26

Technical Indicators

Market Signals
Indicator
ACXP
AIHS
Relative Strength Index (RSI) 43.91 50.08
Support Level $1.37 $1.11
Resistance Level $1.75 $1.48
Average True Range (ATR) 0.14 0.13
MACD 0.02 -0.00
Stochastic Oscillator 39.02 54.79

Price Performance

Historical Comparison
ACXP
AIHS

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: